Cerevel Therapeutics Holdings, Inc. Earnings Per Share, Basic in USD/shares from 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Cerevel Therapeutics Holdings, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2020 to Q1 2024.
  • Cerevel Therapeutics Holdings, Inc. Earnings Per Share, Basic for the quarter ending March 31, 2024 was -0.73 USD/shares, a 8.96% decline year-over-year.
  • Cerevel Therapeutics Holdings, Inc. Earnings Per Share, Basic for the twelve months ending March 31, 2024 was -3 USD/shares, a 7.91% decline year-over-year.
  • Cerevel Therapeutics Holdings, Inc. annual Earnings Per Share, Basic for 2023 was -2.67 USD/shares, a 15.1% decline from 2022.
  • Cerevel Therapeutics Holdings, Inc. annual Earnings Per Share, Basic for 2022 was -2.32 USD/shares, a 40.6% decline from 2021.
  • Cerevel Therapeutics Holdings, Inc. annual Earnings Per Share, Basic for 2021 was -1.65 USD/shares, a 17.9% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)

Cerevel Therapeutics Holdings, Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$3 -$1 $0 -8.96% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 -$3 -$1 $0 -28.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 -$3 -$1 +$0.05 +7.58% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-01
Q2 2023 -$3 -$1 $0 -3.28% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-02
Q1 2023 -$3 -$1 $0 -45.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$2 -$1 Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 -$1 $0 -53.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 -$1 Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q3 2021 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08

Cerevel Therapeutics Holdings, Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$3 $0 -15.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 -$2 -$1 -40.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 -$2 +$0.36 +17.9% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 -$2 Jan 1, 2020 Dec 31, 2020 10-K 2023-02-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.